Carregant...

CAR T-Cell Therapy: On the Verge of Breakthrough in Many Hematologic Malignancies

There have been promising results from clinical trials on the efficacy of engineering patients’ immune cells to treat their cancers. CAR T-cell therapy also has unique toxicities advanced practitioners should be aware of.

Guardat en:
Dades bibliogràfiques
Publicat a:J Adv Pract Oncol
Autors principals: Stadtmauer, Edward, Mangan, Patricia A.
Format: Artigo
Idioma:Inglês
Publicat: Harborside Press 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6003752/
https://ncbi.nlm.nih.gov/pubmed/29928544
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!